Author:
Naser-Hijazi B.,Berger M. R.,Schmähl D.,Schlag P.,Hull W. E.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference26 articles.
1. Aguiar JLA, Berger MR, Frank N (1987a) Locoregional application of 5-fluorouracil to the liver: alteration of pharmacokinetics and bone marrow toxicity in rats with thioacetamide-induced cirrhosis. Toxicol Lett 36:181–188
2. Aguiar JLA, Bartkowski R, Berger MR, Petru E, Schlag P, Schmähl D (1987b) Feasible model for locoregional and systemic longterm administration of drugs and concomitant blood sampling in Sprague-Dawley rats. J Cancer Res Clin Oncol 113:27–30
3. Bartkowski R, Berger MR, Aguiar JLA, Henne TH, Dörsam J, Geelhaar GH, Schlag P, Herfarth C (1986) Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2′-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model. J Cancer Res Clin Oncol 111:42–46
4. Berger MR, Henne TH, Aguiar JLA, Bartkowski R, Dörsam J, Geelhaar GH, Schlag P, Herfarth C, Schmähl D (1986) Experiment on the toxicity of locoregional liver chemotherapy with 5- fluoro-2′-deoxyuridine and 5-fluorouracil in an animal model. Recent Results Cancer Res 100:147–156
5. Bernadou J, Armand JP, Lopez A, Malet-Martino MC, Martino R (1985) Complete urinary excretion profile of 5-fluorouracil during a six-day chemotherapy schedule, as resolved by19F nuclear magnetic resonance. Clin Chem 31:846–848